Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[A patient with thromboangiitis obliterans]

[A patient with thromboangiitis obliterans] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [A patient with thromboangiitis obliterans] Abstract Text:

    BACKGROUND: Thromboangiitis obliterans (Buerger's disease) is characterised by inflammatory thrombi in small and middle-sized arteries and in the veins. As opposed to arteriosclerosis, the vessel wall remains normal. Diagnostic criteria are the presence of distal ischaemia in the extremities, documented by noninvasive vascular testing; exclusion of autoimmune diseases, hypercoagulable states, and diabetes mellitus, age less than 45 years and cigarette smoking. MATERIAL AND METHODS: The article is based on a case history and review of the literature. RESULTS AND INTERPRETATION: A 31-year-old man was in 1953 diagnosed with thromboangiitis obliterans. Lumbar sympathectomy on the left side in 1953 and on the right side in 1971 had excellent symptomatic effect. The patient has been treated with anticoagulants for 48 years. Amputation of the left 2nd toe was performed in 1971. At age 80, he is without further cardiovascular events and takes regular physical exercise. Over the last fifty years, the incidence of thromboangiitis obliterans has been drastically reduced. The reason for this is unknown. The only proven treatment is complete discontinuation of tobacco. The effect of sympathectomy and long-term anticoagulation has not been proven.

    [A patient with thromboangiitis obliterans] Publishing Authors By Initials

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    [A patient with thromboangiitis obliterans] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Tidsskrift for den Norske lægeforening : tidsskrif

    VOLUME: 122

    Page Numbers: 172-3

    Journal Abbreviation: Tidsskr. Nor. Laegeforen.

    ISSN: 0029-2001

    DAY: 20

    MONTH: Jan

    YEAR: 2002

    [A patient with thromboangiitis obliterans] Information

    Number of References:

    LANGUAGE: nor

    NlmUniqueID: 413423

    [A patient with thromboangiitis obliterans] Keywords Mesh Terms:

    KEYWORDS: Toes

    MESH TERMS: surgery

    Chemical & Substance for Abstract: [A patient with thromboangiitis obliterans] Information

    Substance Name: Anticoagulants

    Registry Number: 0

    Grant and Affiliation Information for [A patient with thromboangiitis obliterans]

    AFFILIATION: Medisinsk avdeling Sentralsykehuset i Vestfold 3116 Tønsberg. j-otte@online.no

    Country: Norway

    Norway Research PublicationNorway Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Tidsskr Nor Laegeforen

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    A patient with thromboangiitis obliterans Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News